@docgiorgicchia Profile picture

Giorgia Battipaglia

@docgiorgicchia

Similar User
Vera Radici photo

@RadiciVera

Claire Horgan photo

@Claire_P_Horgan

Simona Pagliuca photo

@pagliuca_simona

Jurgen Kuball photo

@JKuball

Annalisa Ruggeri photo

@AnnalisaRugger1

Christian Chabannon photo

@CChabannon

Bipin Savani photo

@BipinSavani

COSTEM Congress photo

@COSTEMCongress

Paolo Corradini photo

@corradini_paolo

Florent Malard photo

@Florent_Malard

Nicola Polverelli, MD, PhD photo

@N_Polverelli

A Samer Al-Homsi photo

@ASamerAlHomsi1

Panagiotis Christoforou photo

@HaemSummit

Rafaella Muratori photo

@MuratoriMD

Dr. Justin du Toit photo

@clinicalhaemat1

Giorgia Battipaglia Reposted

Real-world application of EBMT best practice guidelines for DLI: room for improvement, but prospective trials are needed to optimize outcomes. @TheEBMT_CTIWP @TheEBMT @SFGM_TC @CIBMTR nature.com/articles/s4140…


Giorgia Battipaglia Reposted

Burnout & moral injury in medicine have affected so many health care workers. As a mid-career physician, here’s what I’ve learned to combat it - I hope others find it to be helpful. In Search of Joy and Meaning in Modern Medicine @JCOOP_ASCO ascopubs.org/doi/pdf/10.120…

Tweet Image 1
Tweet Image 2
Tweet Image 3
Tweet Image 4

Giorgia Battipaglia Reposted

👉🏼🚨Come and join us in Warsaw to discuss all things #MDSsm #MPNsm and allo-HCT/ Cellular therapy. Topics include using molecular risk scores in mds allo algorithms; novel GVhD prophylaxis in MF allo and optimising overlap syndrome outcomes👈🏼

Tweet Image 1

Giorgia Battipaglia Reposted

CONGRESS | #EBMT24 | @docgiorgicchia of @UninaIT talks about the chemo-free approaches with blinatumomab plus TKIs for the treatment of Ph positive ALL. These regimens are feasible and achieve high molecular CRs #ALLsm #leusm #medicalcongress @TheEBMT

Tweet Image 1
Tweet Image 2
Tweet Image 3
Tweet Image 4

Giorgia Battipaglia Reposted

CONGRESS #EBMT24 | @docgiorgicchia @UninaIT discusses the impact of portal and pulmonary hypertension in MF prior to transplant. There is heterogeneity across centres in approaching MF-specific comorbidities prior to transplant, with variable influence on transplant…

Tweet Image 1
Tweet Image 2
Tweet Image 3
Tweet Image 4

Giorgia Battipaglia Reposted

The beauty of #EBMT24 Friends and science.. SAT girls @Mohty_EBMT @docgiorgicchia

Tweet Image 1

Giorgia Battipaglia Reposted

Thrilled to share this piece out in @AjHematology on the Italian cartography of VEXAS | We report on disease features, and clonal dynamics of UBA1 after a variety of therapy including alloHCT 👉 onlinelibrary.wiley.com/doi/full/10.10…


Giorgia Battipaglia Reposted

Happy to share our latest study on PT-Cy! Reducing PT-Cy total dose to 70 mg/kg is associated with ✅Earlier hematopoietic recovery ✅Lower incidences of bacteremia, hemorrhagic cystitis & cardiac events ✅Higher GRFS READ MORE 👉 rdcu.be/djOUS Cc @Mohty_EBMT #bmtsm

Tweet Image 1

Giorgia Battipaglia Reposted

New hope for pts with severe refractory acute GVHD. Just published in @eBioMedicine from the @TheLancet series. Microbiota modulation is a new frontier in hematology and beyond. @Florent_Malard @MaaT_Pharma @TheIACH @TheEBMT_CTIWP

Tweet Image 1
Tweet Image 2
Tweet Image 3

Giorgia Battipaglia Reposted

Join us at the cutting-edge EBMT Educational Meeting on Immunology and Cellular Therapy in Plasma Cell Disorders! 🔬 You can also Submit your abstract before 24 September 2023, and take an active part in the meeting! View the abstract topic list here ⬇️ ebmt.org/events/educati…


Giorgia Battipaglia Reposted

Though the gut microbiome is associated w/ treatment response, the question of how to intervene to promote a positive response remains underexplored. We preview a Cell paper identifying associations btw common drugs & gut microbiome changes in allo-HCT pts bit.ly/465C2d4

Tweet Image 1

Giorgia Battipaglia Reposted

#EBMT2023 - 🏆Best Young Poster Abstract - Finally the results of multicentric #italian #ElastoVOD study! Excellent results of #LiverStiffnessMeasurement on #VOD diagnosis after #HSCT in more than 1000 patients💪🏼

Tweet Image 1

Giorgia Battipaglia Reposted

Again a fantastic oral session on myeloproliferative disorders #EBMT23 moderated by @N_Polverelli and an amazing Alicia Rovo. @CarmeloGurnari presenting an application of the new IPSS-M in MDS patients receiving allogeneic HCT

Tweet Image 1
Tweet Image 2

Giorgia Battipaglia Reposted

Starting #EBMT23 day2 with a comprehensive talk about transplant algorithm in #myelofibrosis #CMWP @DrLornan @TheIACH @TheEBMT #IACHYoungAmbassadors @docgiorgicchia @Mohty_EBMT

Tweet Image 1
Tweet Image 2
Tweet Image 3

Giorgia Battipaglia Reposted

📣📣📣 First ever described patient with #VEXAS and #MDS progressing to #AML. Rare but possible! We here detail clinical and molecular features of it👉 sciencedirect.com/science/articl…


Giorgia Battipaglia Reposted

Prognostic Value of FLT3-Internal Tandem Duplication Residual Disease in Acute Myeloid Leukemia | Journal of Clinical Oncology ascopubs.org/doi/full/10.12…


Giorgia Battipaglia Reposted

Whatever we do in medicine has a history. Hematologists take a sample from the bone marrow (BM) every day. But where do we come from? A short history 🧵 about BM biopsy. #MedTwitter #hematology #pathology

Tweet Image 1

Giorgia Battipaglia Reposted

Thank you @TheIACH, @Mohty_EBMT and all thé Scientific committee for this great initiative. Young and motivated doctors please apply!


Loading...

Something went wrong.


Something went wrong.